1 citations
,
January 2002 in “Journal of Clinical Dermatology” Hair loss in androgenic alopecia may be linked to increased local androgen activities, but not to estrogen levels.
1 citations
,
December 2000 in “The Lancet” Early male hair loss might signal higher heart disease risk.
1 citations
,
August 1999 in “PubMed” Finasteride 1 mg effectively treats male pattern hair loss with minimal side effects.
1 citations
,
January 1996 in “Springer eBooks” Diet affects baldness; eat balanced, less animal fat, more fruits, vegetables, and cereals.
Microinfusion therapy and testosterone use may cause scalp inflammation, requiring early recognition and treatment.
Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.
Finasteride and dutasteride can harm male reproductive health, affecting sperm and causing sexual dysfunction.
April 2026 in “The Journal of Urology” Finasteride and dutasteride reduce semen quality, with dutasteride having a stronger negative effect.
March 2026 in “Mendeley Data” Placebo treatments can significantly affect perceived hair growth in androgenetic alopecia.
March 2026 in “Mendeley Data” Placebo treatments can significantly affect perceived hair growth in androgenetic alopecia.
March 2026 in “Medeniyet Medical Journal” EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.
March 2026 in “Mendeley Data” Placebo treatments can improve hair growth and satisfaction in hair loss.
February 2026 in “Frontiers in Public Health” Lifestyle changes can help manage androgenetic alopecia.
December 2025 in “Journal of Pharmacy And Bioallied Sciences” Personalized Ayurvedic treatment can effectively regrow hair in androgenetic alopecia.
November 2025 in “Cancers” Men with male pattern baldness may have a slightly higher risk of prostate cancer.
November 2025 in “Skin Appendage Disorders” Androgenetic alopecia doesn't increase the risk of heart-related health issues.
September 2025 in “Journal of the American Academy of Dermatology” Reducing SFRP1 can promote hair growth and may help treat hair loss.
August 2025 in “Annals of Medicine” Extracellular vesicles show promise for treating hair loss but need more research for effective use.
August 2025 in “Arabixiv (OSF Preprints)” Male pattern baldness is mainly caused by brain heat stress, not DHT.
July 2025 in “Pakistan Journal of Rehabilitation” Over half of physiotherapy students in Lahore experience hair loss, highlighting the need for better education and early treatment.
June 2025 in “International Journal of Applied Pharmaceutics” A testosterone-induced hair loss model in mice was successfully created for future research and treatment testing.
April 2025 in “Cytotherapy” UC-MSCs derived secretome therapy may help treat hair loss safely.
January 2025 in “Acta Dermatovenerologica Alpina Pannonica et Adriatica” Oral minoxidil boosts hair growth and reduces shedding in androgenetic alopecia.
Mesenchymal stem cell-derived exosomes significantly increase hair density and thickness in androgenic alopecia patients.
August 2024 in “Aesthetic Plastic Surgery” Exosome treatment safely increases hair density in male patients with androgenetic alopecia.
August 2024 in “International Journal of Nursing Studies Advances” Following hair transplant surgery, proper self-care is crucial for successful recovery and hair growth.
August 2024 in “Archives of Dermatological Research” Acne severity is not related to the type or severity of androgenetic alopecia.
July 2024 in “JAAD International” Androgenetic alopecia worsens with age in Japanese men.
July 2024 in “Indian Journal of Dermatology Venereology and Leprology” Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.
July 2024 in “Journal of Education For Sustainable Innovation” Visualizing data helps guide future androgenetic alopecia research and policies.